Quick Answer
Teladoc Health, Inc. reported Net Income Loss of -$200.32 million for the year ending 2025.
- Teladoc Health, Inc. showed an increase of +80.0% in Net Income Loss from 2024 to 2025.
- This data is from Teladoc Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: -$3.20 million | Q3 2014: -$4.53 million | Q1 2015: -$12.70 million | Q2 2015: -$17.06 million | Q3 2015: -$13.25 million | Q1 2016: -$15.30 million | Q2 2016: -$14.88 million | Q3 2016: -$29.77 million | Q4 2016: -$14.26 million | Q1 2017: -$15.65 million | Q2 2017: -$15.42 million | Q3 2017: -$31.33 million | Q4 2017: -$44.38 million | Q1 2018: -$23.86 million | Q2 2018: -$25.08 million | Q3 2018: -$23.26 million | Q4 2018: -$24.88 million | Q1 2019: -$30.15 million | Q2 2019: -$29.32 million | Q3 2019: -$20.35 million | Q4 2019: -$19.04 million | Q1 2020: -$29.60 million | Q2 2020: -$25.68 million | Q3 2020: -$35.88 million | Q1 2021: -$199.65 million | Q2 2021: -$133.82 million | Q3 2021: -$84.34 million | Q1 2022: -$6.67 billion | Q2 2022: -$3.10 billion | Q3 2022: -$73.48 million | Q1 2023: -$69.23 million | Q2 2023: -$65.18 million | Q3 2023: -$57.07 million | Q1 2024: -$81.89 million | Q2 2024: -$837.67 million | Q3 2024: -$33.28 million | Q1 2025: -$93.01 million | Q2 2025: -$32.66 million | Q3 2025: -$49.51 million.
- Over the full 13 years of available data (2013 to 2025), Teladoc Health, Inc.'s Net Income Loss has declined by 3,228.2%.
- Historical annual values: Fiscal year 2025: -$200.32 million | Fiscal year 2024: -$1.00 billion | Fiscal year 2023: -$220.37 million | Fiscal year 2022: -$13.66 billion | Fiscal year 2021: -$428.79 million | Fiscal year 2020: -$485.14 million | Fiscal year 2019: -$98.86 million | Fiscal year 2018: -$97.08 million | Fiscal year 2017: -$106.78 million | Fiscal year 2016: -$74.22 million | Fiscal year 2015: -$58.02 million | Fiscal year 2014: -$17.04 million | Fiscal year 2013: -$6.02 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: